Viewing Study NCT06198751


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2025-12-26 @ 5:48 PM
Study NCT ID: NCT06198751
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2023-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module